Skip to main content
TRISTEL PLC logo

TRISTEL PLC — Investor Relations & Filings

Ticker · TSTL ISIN · GB00B07RVT99 LEI · 2138009DZ4LH9CZGF662 IL Manufacturing
Open in API
Filings indexed 453 across all filing types
Latest filing 2023-03-27 Regulatory Filings
Country GB United Kingdom
Listing IL TSTL

About TRISTEL PLC

https://www.tristel.com/

Tristel PLC is an infection prevention company that develops, manufactures, and sells disinfection products based on its proprietary chlorine dioxide (ClO2) chemistry. The company's solutions are designed to halt the transmission of microbes in healthcare settings, with a focus on the high-level disinfection of medical devices and surfaces. Key products include the Tristel Trio Wipes System, a comprehensive solution for the decontamination of medical instruments at the point of care. Tristel supports its offerings with services such as training, research and development, product validation, and the 3T digital compliance application, which provides traceability and an audit trail for decontamination procedures.

Recent filings

Filing Released Lang Actions
Successful submission of additional data to US FDA
Regulatory Filings Classification · 100% confidence The document starts with an RNS Number and is dated March 27, 2023. It announces a specific corporate event: the successful submission of additional data to the US FDA regarding a De Novo submission for a product (Duo ULT). This is a material, non-financial operational update concerning regulatory progress and market access. It is not a full financial report (10-K, IR), an earnings release (ER), a management discussion (MDA), or a proxy statement (DEF 14A). Since it is a specific, material announcement distributed via the RNS system, and it doesn't fit neatly into the other specific categories like Director's Dealing (DIRS) or Capital Change (CAP), it falls best under the general regulatory announcement category, RNS, which serves as the fallback for miscellaneous regulatory news releases.
2023-03-27 English
Second Price Monitoring Extn
Regulatory Filings Classification · 98% confidence The document begins with 'RNS Number : 9533S' and is dated March 14, 2023. The content describes a 'Second Price Monitoring Extension' related to trading activity on the London Stock Exchange, which is a specific operational announcement. The text explicitly states, 'This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom.' This strongly indicates that the document is a general regulatory announcement disseminated via the RNS system, rather than a specific financial report (like 10-K, IR, or ER). Since it is a regulatory announcement that doesn't fit the highly specific categories (like DIRS, DIV, or DLST), the most appropriate classification is the general regulatory fallback category.
2023-03-14 English
Price Monitoring Extension
Regulatory Filings Classification · 99% confidence The document is very short (1909 characters) and contains the header 'RNS Number : 9524S'. It announces a 'Price Monitoring Extension' related to trading procedures on the London Stock Exchange. It explicitly states, 'This information is provided by RNS, the news service of the London Stock Exchange.' This strongly indicates it is a general regulatory announcement disseminated via the RNS system, rather than a specific financial report like an ER, 10-K, or IR. Since it is a general regulatory announcement that doesn't fit the other specific categories (like DIRS, DIV, or MANG), the most appropriate classification is the general regulatory filing fallback.
2023-03-14 English
Issue of Equity
Share Issue/Capital Change Classification · 99% confidence The document is an official announcement disseminated via RNS (Regulatory News Service) from the London Stock Exchange. The content explicitly details the 'Exercise of Share Options' resulting in the issuance of 4,000 new ordinary shares and updates the 'Total Voting Rights'. This action directly relates to a change in the company's share capital structure. While it involves share issuance (related to SHA), the primary nature of this specific RNS filing, which reports on the immediate consequence of an option exercise and the resulting total share count used for regulatory disclosure (FCA's Disclosure Guidance), fits best under the general regulatory announcement category, RNS, or potentially SHA (Share Issue/Capital Change). Given the structure and the explicit mention of RNS Number and the LSE distribution boilerplate, RNS is a strong candidate. However, since the core event is the issuance of new shares following option exercise, SHA (Share Issue/Capital Change) is more specific than the general RNS fallback. The document announces a change in the number of shares in issue, which is the definition of SHA.
2023-03-14 English
Issue of Equity
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is identified by the RNS Number (7531Q) and explicitly states it is provided by RNS, the news service of the London Stock Exchange. The content announces the 'Exercise of Share Options' resulting in the issuance of new ordinary shares and provides the resulting 'Total Voting Rights'. This action directly relates to a change in the company's capital structure (issuance of new shares) and is a mandatory regulatory disclosure. While it involves share issuance (SHA), the primary context is a formal regulatory announcement distributed via the RNS system, which often serves as the initial dissemination point for such corporate actions. Given the options, 'Share Issue/Capital Change' (SHA) is the most specific fit for the core event (issuance of new shares), but since it is distributed via RNS and is a short, formal announcement, 'Regulatory Filings' (RNS) is also a strong candidate if the focus is on the distribution mechanism. However, the core subject is the change in share capital. Since the document details the exact number of shares issued and the resulting total voting rights, it fits best under 'Share Issue/Capital Change' (SHA), as it is a specific corporate action disclosure, rather than a general regulatory filing (RNS) or a simple announcement of a report (RPA). The length is short, but the content is substantive regarding capital structure.
2023-02-22 English
Half-year Report
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Half-year Report' and 'Unaudited Interim Results for the six months ended 31 December 2022'. It contains comprehensive financial statements, including the Condensed Consolidated Income Statement, Statement of Comprehensive Income, and Statement of Financial Position. It is a substantive financial report for a period shorter than a full fiscal year, fitting the definition of an Interim/Quarterly Report (IR). H1 2023
2023-02-20 English

Browse filings by year

22 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.